Mercury Laboratories Limited (BOM:538964)
India
· Delayed Price · Currency is INR 829.00
+4.00 (0.48%)
At close: Jun 6, 2025
Mercury Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 751.01 | 755.59 | 753.34 | 579.24 | 686.02 | Upgrade
|
| Revenue | 751.01 | 755.59 | 753.34 | 579.24 | 686.02 | Upgrade
|
| Revenue Growth (YoY) | -0.61% | 0.30% | 30.06% | -15.57% | 19.79% | Upgrade
|
| Cost of Revenue | 289.16 | 325.43 | 328.94 | 247.77 | 322.43 | Upgrade
|
| Gross Profit | 461.85 | 430.16 | 424.39 | 331.46 | 363.59 | Upgrade
|
| Selling, General & Admin | 168.41 | 145.01 | 142.45 | 124.97 | 98 | Upgrade
|
| Other Operating Expenses | 212.59 | 178.13 | 189 | 134.96 | 159.23 | Upgrade
|
| Operating Expenses | 409.76 | 365.75 | 361.11 | 284.6 | 286.89 | Upgrade
|
| Operating Income | 52.09 | 64.41 | 63.28 | 46.87 | 76.7 | Upgrade
|
| Interest Expense | -5.48 | -0.65 | -0.57 | -1.7 | -2.54 | Upgrade
|
| Interest & Investment Income | - | 1.2 | 1.24 | 0.88 | 0.58 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 4.58 | 12.4 | 4.31 | 2.73 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -1.01 | -1.63 | -1.52 | 1.55 | Upgrade
|
| EBT Excluding Unusual Items | 46.62 | 68.53 | 74.71 | 48.84 | 79.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.68 | -0.27 | 0.23 | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.28 | - | Upgrade
|
| Pretax Income | 46.62 | 69.2 | 74.45 | 50.34 | 79.09 | Upgrade
|
| Income Tax Expense | 15.17 | 12.66 | 18.66 | 14.73 | 25.72 | Upgrade
|
| Net Income | 31.45 | 56.54 | 55.79 | 35.62 | 53.38 | Upgrade
|
| Net Income to Common | 31.45 | 56.54 | 55.79 | 35.62 | 53.38 | Upgrade
|
| Net Income Growth | -44.38% | 1.35% | 56.62% | -33.27% | 65.34% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | - | - | - | Upgrade
|
| EPS (Basic) | 26.21 | 47.12 | 46.49 | 29.68 | 44.48 | Upgrade
|
| EPS (Diluted) | 26.21 | 47.12 | 46.49 | 29.68 | 44.48 | Upgrade
|
| EPS Growth | -44.37% | 1.35% | 56.64% | -33.27% | 65.34% | Upgrade
|
| Free Cash Flow | -50.39 | 19.53 | 13.96 | 32.74 | 35.95 | Upgrade
|
| Free Cash Flow Per Share | -41.99 | 16.28 | 11.63 | 27.29 | 29.95 | Upgrade
|
| Dividend Per Share | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 | Upgrade
|
| Dividend Growth | - | - | - | - | 75.00% | Upgrade
|
| Gross Margin | 61.50% | 56.93% | 56.34% | 57.22% | 53.00% | Upgrade
|
| Operating Margin | 6.94% | 8.52% | 8.40% | 8.09% | 11.18% | Upgrade
|
| Profit Margin | 4.19% | 7.48% | 7.41% | 6.15% | 7.78% | Upgrade
|
| Free Cash Flow Margin | -6.71% | 2.58% | 1.85% | 5.65% | 5.24% | Upgrade
|
| EBITDA | 80.85 | 85.58 | 84.14 | 67.39 | 95.74 | Upgrade
|
| EBITDA Margin | 10.77% | 11.33% | 11.17% | 11.63% | 13.96% | Upgrade
|
| D&A For EBITDA | 28.76 | 21.17 | 20.86 | 20.52 | 19.04 | Upgrade
|
| EBIT | 52.09 | 64.41 | 63.28 | 46.87 | 76.7 | Upgrade
|
| EBIT Margin | 6.94% | 8.52% | 8.40% | 8.09% | 11.18% | Upgrade
|
| Effective Tax Rate | 32.54% | 18.30% | 25.06% | 29.25% | 32.51% | Upgrade
|
| Revenue as Reported | 761.7 | 766.48 | 770.53 | 587.4 | 694.82 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.